跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FRIMInc Patawali Extract 50mg Capsule - NPRA Drug Approval Details
Approvals
/
NPRA
/
FRIMInc Patawali Extract 50mg Capsule
Approved
STANDARD
FRIMInc Patawali Extract 50mg Capsule
FRIM INCORPORATED SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Jan 17, 2026
Approval ID
0ae0d1cd71bfd129
Company
FRIM INCORPORATED SDN. BHD.
Type
Standard
Approval Details
Approval Id
0ae0d1cd71bfd129
Drug Approval Npra Name
FRIMInc Patawali Extract 50mg Capsule
Product Name
FRIMInc Patawali Extract 50mg Capsule
Registration Number
MAL26016158TC
Holder Company Name
FRIM INCORPORATED SDN. BHD.
Holder Address
JKR 629, WISMA FRIM INC, JALAN WATSON, FRIM 52109 KEPONG MALAYSIA
Holder Phone
01110962871
Manufacturer Company Name
PUSAT TEKNOLOGI HERBA
Manufacturer Address
INSTITUT PENYELIDIKAN PERHUTANAN MALAYSIA 52109 KEPONG MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL26016158TC
Version
1768678493
Active Ingredients
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Jan 17, 2026
Approval ID
0ae0d1cd71bfd129
Type
Standard
Source
Official Source
Back to NPRA Approvals